153 related articles for article (PubMed ID: 24191416)
1. [Infectious complications in elderly with chronic hematological malignancies].
Berlier C; Erard V
Rev Med Suisse; 2013 Oct; 9(401):1821-6. PubMed ID: 24191416
[TBL] [Abstract][Full Text] [Related]
2. Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997-2001).
Guven GS; Uzun O; Cakir B; Akova M; Unal S
Support Care Cancer; 2006 Jan; 14(1):52-5. PubMed ID: 15947955
[TBL] [Abstract][Full Text] [Related]
3. Infectious diseases in the elderly: an overview.
Meyers BR
Geriatrics; 1989 Aug; 44 Suppl A():4-6. PubMed ID: 2673938
[TBL] [Abstract][Full Text] [Related]
4. Secondary immunodeficiency in lymphoproliferative malignancies.
Friman V; Winqvist O; Blimark C; Langerbeins P; Chapel H; Dhalla F
Hematol Oncol; 2016 Sep; 34(3):121-32. PubMed ID: 27402426
[TBL] [Abstract][Full Text] [Related]
5. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
6. Advances and challenges in infectious diseases supportive care of patients with hematologic malignancies, hematopoietic stem cell transplantation, and severe aplastic anemia.
Walsh TJ
Semin Hematol; 2009 Jul; 46(3):191-7. PubMed ID: 19549573
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of patients with hematological malignancies at gondar university hospital, North West Ethiopia.
Weldetsadik AT
Ethiop Med J; 2013 Jan; 51(1):25-31. PubMed ID: 23930488
[TBL] [Abstract][Full Text] [Related]
8. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
10. Supportive care in hematologic malignancies, including hematopoietic growth factors, transfusions, and infectious complications.
Fetscher S; Mertelsmann R
Curr Opin Hematol; 1997 Jul; 4(4):248-55. PubMed ID: 9260052
[TBL] [Abstract][Full Text] [Related]
11. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis.
Sari I; Altuntas F; Hacioglu S; Kocyigit I; Sevinc A; Sacar S; Deniz K; Alp E; Eser B; Yildiz O; Kaynar L; Unal A; Cetin M
Am J Hematol; 2008 Apr; 83(4):334-9. PubMed ID: 18069671
[TBL] [Abstract][Full Text] [Related]
12. Sequelae and complications related to dental extractions in patients with hematologic malignancies and the impact on medical outcome.
Raut A; Huryn JM; Hwang FR; Zlotolow IM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jul; 92(1):49-55. PubMed ID: 11458245
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and Beyond: Infections in the Era of Old and New Treatments for Hematologic Malignancies.
Atkins S; He F
Infect Dis Clin North Am; 2019 Jun; 33(2):289-309. PubMed ID: 30935703
[TBL] [Abstract][Full Text] [Related]
14. Patterns of hematological and non-hematological malignancies in bone marrow in a tertiary care hospital in Nepal--11 years study.
Ghartimagar D; Ghosh A; Narasimhan R; Talwar OP
Nepal Med Coll J; 2012 Sep; 14(3):187-92. PubMed ID: 24047012
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. A protocol for the evaluation and treatment of oral mucositis in patients with hematological malignancies.
Puyalt Casado M; Jiménez Martinez C; Chimenos Küstner E; López López J; Juliá A
Med Oral; 2003; 8(1):10-8. PubMed ID: 12556718
[TBL] [Abstract][Full Text] [Related]
17. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary tuberculosis in patients with hematological malignancies].
Adzić T
Med Pregl; 2004; 57 Suppl 1():65-8. PubMed ID: 15686225
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic risk in hematological malignancies.
Franchini M
Clin Chem Lab Med; 2015 Jul; 53(8):1139-47. PubMed ID: 25503466
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in the management of invasive fungal infections in patients with hematological malignancies.
Karthaus M; Cornely OA
Ann Hematol; 2005 Apr; 84(4):207-16. PubMed ID: 15614521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
